ஸெநெக பார்மா இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஸெநெக பார்மா இந்தியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஸெநெக பார்மா இந்தியா Today - Breaking & Trending Today

AstraZeneca Pharma India Ltd Q1FY22 PAT at Rs. 10.24 crore

AstraZeneca Pharma India Ltd Q1FY22 PAT at Rs. 10.24 crore
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Astrazeneca Pharma India Ltd , Time Zone , Zeneca Pharma India , Astrazeneca Pharma India , நேரம் ஸோந் , ஸெநெக பார்மா இந்தியா ,

Tech Query: Should I hold AstraZeneca Pharma India stock? - The Hindu BusinessLine

Tech Query: Should I hold AstraZeneca Pharma India stock? - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Procter Gamble Health , Gamble Health , Zeneca Pharma India , ப்ராக்‌டர் சூதாட்டம் ஆரோக்கியம் , சூதாட்டம் ஆரோக்கியம் , ஸெநெக பார்மா இந்தியா ,

Sensex, Nifty Pre-Market Cues: All You Need To Know Going Into Trade On July 19

Net profit Rs 7,729.62 crore vs estimate Rs 7,931 crore.
Net interest income Rs 17,009 crore vs. estimate Rs 17,634 crore
GNPA: 1.47% vs 1.32% (QoQ)
NNPA: 0.48% vs 0.4% (QoQ)
Advances rose 14.4% YoY to Rs 11.47 lakh crore.
Been through unprecedented times last year and even this financial year, Sashidhar Jagdishan, MD & CEO, HDFC Bank said. He said the these are the worst of times the bank could have been through but the results were reasonably healthy .
Justdial (Q1FY22, Consolidated, QoQ)
Revenue down nearly 6% at Rs 165.4 crore vs Rs 175.7 crore
To optimize discretionary costs, the company had curtailed its advertising spends in FY21.
However, advertising spends accelerated to nearly Rs 50 crore during Q1FY22 to promote the newly launched B2B platform, JD Mart. ....

Tamil Nadu , Subhash Chand Aggarwal , Indian Overseas Bank , Reliance Industries Ltd , Athena Life Sciences , Canara Bank , Reliance Retail Ventures Ltd , National Company Law Tribunal , Indian Bank , Life Insurance Company , Just Dial Ltd , Kirloskar Ferrous Industries , Kirloskar Industries , Kirloskar Oil Engines , Kirloskar Group , Alok Industries , Punjab Chemicals , Crop Protection , Cyclone Tauktae , Kirloskar Chillers , Kirloskar Pneumatic , Plyboards India , Century Infotech , Zeneca Pharma India , Ex Tica Growth , India Ratings ,

AstraZeneca rejigs diabetes drug deal with Sun Pharma

AstraZeneca rejigs diabetes drug deal with Sun Pharma
ultra.news - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ultra.news Daily Mail and Mail on Sunday newspapers.

United Kingdom , Sun Pharma , Astrazeneca Pharma India , Pharma Company , Zeneca Pharma India , Astrazeneca Pharma India Limited , Transition Supply Agreement , Astrazeneca India , Abbott Healthcare , ஒன்றுபட்டது கிஂக்டம் , சூரியன் பார்மா , பார்மா நிறுவனம் , ஸெநெக பார்மா இந்தியா , அப்போட் சுகாதாரம் ,

AstraZeneca Pharma gains after Q4 PAT soars 185% to Rs 27 cr

Read more about AstraZeneca Pharma gains after Q4 PAT soars 185% to Rs 27 cr on Business Standard. AstraZeneca Pharma India rose 1.46% to Rs 3,918.85 after the company s net profit surged 184.95% to Rs 27.27 crore on 7.88% increase in revenue from operations to Rs 210.25 crore in Q4 March 2021 over Q4 March 2020. ....

United Kingdom , Astrazeneca Plc , Astrazeneca Pharma India , Zeneca Pharma India , Capital Market , Medical Research , Dertlje Municipality , Life Sciences , Harmaceuticals Nec , Astrazeneca Plc , United Kingdom , Metabolic Diseases , Astrazeneca Pharma India , ஒன்றுபட்டது கிஂக்டம் , ஸெநெக பார்மா இந்தியா , மூலதனம் சந்தை ,